US Edition
Published • loading... • Updated
NG Biotech announces FDA approval for diagnostic assays
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Medical Device NetworkReposted by 
Verdict Hospital
Verdict HospitalNG Biotech announces FDA approval for diagnostic assays
NG Biotech and Hardy Diagnostics have received the US FDA breakthrough device designation for two rapid diagnostic assays, NG-TEST Candida auris and NG-TEST Acineto-5 targeting critical drug-resistant pathogens.The post NG Biotech announces FDA approval for diagnostic assays appeared first on Medical Device Network.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
